A study on triggers of migraine and quality of life of migraine patients
Abstract
Our study delved into the complex realm of migraine, an extensive and disabling neurological condition, with a dual focus on uncovering its triggers and evaluating the quality of life (QoL) experienced by patients. We recruited migraine patients aged 16 years and above, excluding individuals with co-morbidities or undergoing cancer-related treatments, resulting in a cohort of 200 participants, among whom 78.5% were female and 21.5% were male, primarily concentrated (32.5%) in the 26-35 age group. A notable 56.6% had a familial history of migraine. Of the 190 patients encountering pain, 61.05% reported severe headache intensification triggered by noise, and 56.84% by exposure to light. The study identified several significant triggers, including emotional stress (97.5%), physical exertion (64.5%), traveling (55.5%), sleep deprivation (55%), missed meals (63.5%), and weather change (69%). Assessment via the MIDAS questionnaire highlighted that over 69.5% of patients experienced moderate to severe disability due to migraine, while WHOQOL-Bref data indicated a notably poor QoL among these individuals. Our findings underscore the substantial impact of migraine on the lives of sufferers, emphasizing the pressing need for tailored counseling and robust psychological support to augment treatment efficacy. This comprehensive understanding of triggers and their consequent effects underscores the importance of personalized care to alleviate the considerable burden endured by…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 200 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.